Baidu
map

2019 ADA临床实践指南:抗生素在牙髓和根尖周相关牙痛以及口腔内肿胀紧急管理中的应用

2019-11-02 美国牙科协会 J Am Dent Assoc. 2019 Nov;150(11):906-921.e12.

2019年11月,美国牙科协会(ADA)发布了抗生素在牙髓和根尖周相关牙痛以及口腔内肿胀紧急管理中的应用指南,文章主要针对症状性不可逆性牙髓炎伴或不伴有症状性根尖周炎,牙髓坏死以及症状性根尖周炎或局限性急性根尖脓肿的紧急抗生素治疗提供指导建议。

中文标题:

2019 ADA临床实践指南:抗生素在牙髓和根尖周相关牙痛以及口腔内肿胀紧急管理中的应用

英文标题:

Evidence-based clinical practice guideline on antibiotic use for the urgent management of pulpal- and periapical-related dental pain and intraoral swelling: A report from the American Dental Association.

发布机构:

美国牙科协会

发布日期:

2019-11-02

简要介绍:

2019年11月,美国牙科协会(ADA)发布了抗生素在牙髓和根尖周相关牙痛以及口腔内肿胀紧急管理中的应用指南,文章主要针对症状性不可逆性牙髓炎伴或不伴有症状性根尖周炎,牙髓坏死以及症状性根尖周炎或局限性急性根尖脓肿的紧急抗生素治疗提供指导建议。

 

拓展指南:抗生素相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 ADA临床实践指南:抗生素在牙髓和根尖周相关牙痛以及口腔内肿胀紧急管理中的应用)] GetToolGuiderByIdResponse(projectId=1, id=a94a51c0018283af, title=2019 ADA临床实践指南:抗生素在牙髓和根尖周相关牙痛以及口腔内肿胀紧急管理中的应用, enTitle=Evidence-based clinical practice guideline on antibiotic use for the urgent management of pulpal- and periapical-related dental pain and intraoral swelling: A report from the American Dental Association., guiderFrom=J Am Dent Assoc. 2019 Nov;150(11):906-921.e12., authorId=null, author=, summary=2019年11月,美国牙科协会(ADA)发布了抗生素在牙髓和根尖周相关牙痛以及口腔内肿胀紧急管理中的应用指南,文章主要针对症状性不可逆性牙髓炎伴或不伴有症状性根尖周炎,牙髓坏死以及症状性根尖周炎或局限性急性根尖脓肿的紧急抗生素治疗提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=50, associationName=美国牙科协会, associationIntro=美国牙医协会成立于1859年,是美国在世界上历史最悠久,规模最大的牙科协会,此后,ADA已成为牙科医生和病人口腔健康相关信息的主要来源。ADA拥有来自50个州的超过156,000的成员。其官方杂志是The Journal of the American Dental Association, copyright=0, guiderPublishedTime=Sat Nov 02 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年11月,美国牙科协会(ADA)发布了抗生素在牙髓和根尖周相关牙痛以及口腔内肿胀紧急管理中的应用指南,文章主要针对症状性不可逆性牙髓炎伴或不伴有症状性根尖周炎,牙髓坏死以及症状性根尖周炎或局限性急性根尖脓肿的紧急抗生素治疗提供指导建议。 </P> <P> </P>拓展指南:<strong>与<font color=red>抗生素</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=0617a1c001e593f8" title="2019 KSID指南:抗生素在急性胃肠炎中的应用" target=_blank>2019 KSID指南:抗生素在急性胃肠炎中的应用</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=783641c001e571ed" title="2019 SFPT/SFAR指南:优化重症患者β-内酰胺类抗生素治疗" target=_blank>2019 SFPT/SFAR指南:优化重症患者β-内酰胺类抗生素治疗</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=af5421c001e02577" title="2019 国际专家共识:降钙素原(PCT)指导抗生素管理" target=_blank>2019 国际专家共识:降钙素原(PCT)指导抗生素管理</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=28e461c0016609c5" title="2018 共识报告:非手术牙周治疗期间全身性抗生素的应用" target=_blank>2018 共识报告:非手术牙周治疗期间全身性抗生素的应用</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=8edda1c0016a98f5" title="浙江省头孢菌素类抗生素皮肤过敏试验指导意见" target=_blank>浙江省头孢菌素类抗生素皮肤过敏试验指导意见</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E6%8A%97%E7%94%9F%E7%B4%A0" target=_blank>有关抗生素更多指南</a></ul>, tagList=[TagDto(tagId=1828, tagName=抗生素), TagDto(tagId=53937, tagName=牙髓炎), TagDto(tagId=96853, tagName=根尖周相关牙痛), TagDto(tagId=96854, tagName=口腔内肿胀)], categoryList=[CategoryDto(categoryId=31, categoryName=口腔科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=21521, appHits=304, showAppHits=4, pcHits=3155, showPcHits=19516, likes=56, shares=14, comments=9, approvalStatus=1, publishedTime=Mon Nov 18 01:16:20 CST 2019, publishedTimeString=2019-11-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Nov 18 01:16:20 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 08:22:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ADA临床实践指南:抗生素在牙髓和根尖周相关牙痛以及口腔内肿胀紧急管理中的应用)])
2019 ADA临床实践指南:抗生素在牙髓和根尖周相关牙痛以及口腔内肿胀紧急管理中的应用
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1188427, encodeId=99e2118842ed2, content=详细客观, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c86477226, createdName=ms5000002138253687, createdTime=Wed Jan 26 22:25:14 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010293, encodeId=1b8d1010293e3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfed5581097, createdName=陈姗, createdTime=Sun Aug 22 14:51:27 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002493, encodeId=f7e71002493bc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=ms8000001011137665, createdTime=Sun Jul 25 13:14:40 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001939, encodeId=73b610019396b, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210723/d08c69a5b86648ee960d5bae47add174/679989a4ee6d47ca83bd3a4ec8396c22.jpg, createdBy=b5665541960, createdName=ms9000000897883030, createdTime=Fri Jul 23 10:01:34 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001938, encodeId=f49b10019385d, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210723/d08c69a5b86648ee960d5bae47add174/679989a4ee6d47ca83bd3a4ec8396c22.jpg, createdBy=b5665541960, createdName=ms9000000897883030, createdTime=Fri Jul 23 10:01:01 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2022-01-26 ms5000002138253687

    详细客观

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1188427, encodeId=99e2118842ed2, content=详细客观, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c86477226, createdName=ms5000002138253687, createdTime=Wed Jan 26 22:25:14 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010293, encodeId=1b8d1010293e3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfed5581097, createdName=陈姗, createdTime=Sun Aug 22 14:51:27 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002493, encodeId=f7e71002493bc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=ms8000001011137665, createdTime=Sun Jul 25 13:14:40 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001939, encodeId=73b610019396b, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210723/d08c69a5b86648ee960d5bae47add174/679989a4ee6d47ca83bd3a4ec8396c22.jpg, createdBy=b5665541960, createdName=ms9000000897883030, createdTime=Fri Jul 23 10:01:34 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001938, encodeId=f49b10019385d, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210723/d08c69a5b86648ee960d5bae47add174/679989a4ee6d47ca83bd3a4ec8396c22.jpg, createdBy=b5665541960, createdName=ms9000000897883030, createdTime=Fri Jul 23 10:01:01 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-08-22 陈姗

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1188427, encodeId=99e2118842ed2, content=详细客观, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c86477226, createdName=ms5000002138253687, createdTime=Wed Jan 26 22:25:14 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010293, encodeId=1b8d1010293e3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfed5581097, createdName=陈姗, createdTime=Sun Aug 22 14:51:27 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002493, encodeId=f7e71002493bc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=ms8000001011137665, createdTime=Sun Jul 25 13:14:40 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001939, encodeId=73b610019396b, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210723/d08c69a5b86648ee960d5bae47add174/679989a4ee6d47ca83bd3a4ec8396c22.jpg, createdBy=b5665541960, createdName=ms9000000897883030, createdTime=Fri Jul 23 10:01:34 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001938, encodeId=f49b10019385d, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210723/d08c69a5b86648ee960d5bae47add174/679989a4ee6d47ca83bd3a4ec8396c22.jpg, createdBy=b5665541960, createdName=ms9000000897883030, createdTime=Fri Jul 23 10:01:01 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-07-25 ms8000001011137665

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1188427, encodeId=99e2118842ed2, content=详细客观, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c86477226, createdName=ms5000002138253687, createdTime=Wed Jan 26 22:25:14 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010293, encodeId=1b8d1010293e3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfed5581097, createdName=陈姗, createdTime=Sun Aug 22 14:51:27 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002493, encodeId=f7e71002493bc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=ms8000001011137665, createdTime=Sun Jul 25 13:14:40 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001939, encodeId=73b610019396b, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210723/d08c69a5b86648ee960d5bae47add174/679989a4ee6d47ca83bd3a4ec8396c22.jpg, createdBy=b5665541960, createdName=ms9000000897883030, createdTime=Fri Jul 23 10:01:34 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001938, encodeId=f49b10019385d, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210723/d08c69a5b86648ee960d5bae47add174/679989a4ee6d47ca83bd3a4ec8396c22.jpg, createdBy=b5665541960, createdName=ms9000000897883030, createdTime=Fri Jul 23 10:01:01 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-07-23 ms9000000897883030

    非常有用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1188427, encodeId=99e2118842ed2, content=详细客观, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c86477226, createdName=ms5000002138253687, createdTime=Wed Jan 26 22:25:14 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010293, encodeId=1b8d1010293e3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfed5581097, createdName=陈姗, createdTime=Sun Aug 22 14:51:27 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002493, encodeId=f7e71002493bc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=ms8000001011137665, createdTime=Sun Jul 25 13:14:40 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001939, encodeId=73b610019396b, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210723/d08c69a5b86648ee960d5bae47add174/679989a4ee6d47ca83bd3a4ec8396c22.jpg, createdBy=b5665541960, createdName=ms9000000897883030, createdTime=Fri Jul 23 10:01:34 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001938, encodeId=f49b10019385d, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210723/d08c69a5b86648ee960d5bae47add174/679989a4ee6d47ca83bd3a4ec8396c22.jpg, createdBy=b5665541960, createdName=ms9000000897883030, createdTime=Fri Jul 23 10:01:01 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-07-23 ms9000000897883030

    有用

    0

Baidu
map
Baidu
map
Baidu
map